Jeffrey V. Poulton insider trades
Open-market stock purchases and sales by Jeffrey V. Poulton, Director at CervoMed Inc, from SEC Form 4 filings since Oct 10, 2019.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 8, 2026 | CRVO CervoMed Inc | Bought (not open market) | — |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $94.5K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $72.6K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $121K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $36.4K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $34.9K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $73.8K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $99.4K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $265K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $116K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $177K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $149K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $45.4K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $77.2K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $37.1K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $42.8K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $21K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $40.3K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $17.6K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 27, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 13, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $695K |
| Feb 12, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 12, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $25.5K |